Search
Relugolix
go.drugbank.com/drugs/DB11853ApprovedInvestigationalRelugolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist used in the treatment of several hormone-responsive conditions. … [A225761] Relugolix is the first (and currently only) orally-administered GnRH receptor antagonist approved for the treatment of prostate cancer - similar therapies such as [degarelix] require subcutaneous
Categories: P-glycoprotein inhibitors, P-glycoprotein substratesAlvelestat
go.drugbank.com/drugs/DB11863InvestigationalAlvelestat has been investigated for the basic science of Chronic Obstructive Pulmonary Disease.
Categories: Heterocyclic Compounds, 1-RingJNJ-39393406
go.drugbank.com/drugs/DB11867InvestigationalJNJ-39393406 has been used in trials studying the treatment and basic science of DEPRESSION, Schizophrenia, Smoking Cessation, Cognition Disorders, and Alzheimer's Disease.
Categories: Heterocyclic Compounds, 1-RingEtiracetam
go.drugbank.com/drugs/DB11868ExperimentalEtiracetam is under investigation in clinical trial NCT01137110 (Comparison of Short Duration Levetiracetam to Extended Course for Seizure Prophylaxis After Subarachnoid Hemorrhage (SAH)).
Categories: Heterocyclic Compounds, 1-RingValspodar
go.drugbank.com/drugs/DB11869InvestigationalValspodar has been used in trials studying the treatment of Cancer, Sarcoma, Leukemia, Lymphoma, and Breast Cancer, among others.
Categories: ATP Binding Cassette Transporter, Subfamily B, Member 1, P-glycoprotein inhibitorsPiromidic acid
go.drugbank.com/drugs/DB13744InvestigationalCategories: Heterocyclic Compounds, 1-RingFazadinium bromide
go.drugbank.com/drugs/DB13745ExperimentalCategories: Heterocyclic Compounds, 1-RingTetramethrin
go.drugbank.com/drugs/DB13752ExperimentalCategories: MATE 1 Inhibitors, P-glycoprotein inhibitorsEpanolol
go.drugbank.com/drugs/DB13757ExperimentalEpanolol is an beta blocker.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2D6 Substrates